Secondary endpoints are relapse rate ( up to day 90 ) , speed of recovery ( using a cellulitis severity score until day 28 , and VAS scores on pain and swelling until day 90 ) , quality of life ( using the SF-36 and EQ-5D questionnaires ) and costs ( associated with total antibiotic use and health-care resource utilization up to day 90 ) .